Form 4: STERIS plc Executive Cary L. Majors Sells 2,024 Shares

Cary L. Majors, SVP and President, Healthcare at STERIS plc, sold 2,024 ordinary shares of the company on May 13, 2024, at a weighted average price of $232.13 per share.

Summary

• On May 13, 2024, Cary L. Majors, an SVP and President at STERIS plc, sold 2,024 ordinary shares of the company.
• The sale was executed at a weighted average price of $232.13 per share.
• Following the transaction, Majors directly owns 11,369 ordinary shares of STERIS plc.
• 9,860 of these shares are restricted and will vest over time, with varying amounts vesting on June 3, 2024, June 2, 2025, October 1, 2025, June 1, 2026, and June 2, 2026.

Sentiment

Score: 5

Explanation: The document is a neutral report of an insider transaction. It doesn't inherently convey positive or negative sentiment.

Industry Context

This filing is a routine disclosure of insider trading activity. It provides transparency to investors regarding the transactions of company executives.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies and their insiders.
• The information disclosed is consistent with regulatory requirements for insider trading reporting.
• Comparable companies such as Getinge and Cantel Medical also have similar insider trading reporting requirements.

Stakeholder Impact

• The sale of shares by an executive could be perceived negatively by some shareholders, but it is a relatively small transaction.
• The impact on employees, customers, suppliers, and creditors is likely minimal.

Key Dates